Paragon 28 (FNA) Scheduled to Post Quarterly Earnings on Thursday

Paragon 28 (NYSE:FNA) is scheduled to issue its quarterly earnings data after the market closes on Thursday, August 8th. Analysts expect the company to announce earnings of ($0.15) per share for the quarter. Parties interested in participating in the company’s conference call can do so using this link.

Paragon 28 (NYSE:FNA) last announced its earnings results on Wednesday, May 8th. The company reported ($0.18) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.11) by ($0.07). Paragon 28 had a negative net margin of 24.45% and a negative return on equity of 27.72%. The business had revenue of $61.08 million for the quarter. On average, analysts expect Paragon 28 to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Paragon 28 Stock Up 6.6 %

Shares of NYSE:FNA opened at $7.62 on Wednesday. Paragon 28 has a 1 year low of $5.55 and a 1 year high of $15.72. The business has a 50 day simple moving average of $7.21 and a two-hundred day simple moving average of $9.57. The firm has a market capitalization of $632.09 million, a PE ratio of -11.72 and a beta of 0.99. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.57 and a quick ratio of 1.78.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on FNA. Needham & Company LLC lowered their price target on Paragon 28 from $17.00 to $14.00 and set a “buy” rating for the company in a report on Thursday, May 9th. JMP Securities lowered their price target on Paragon 28 from $23.00 to $20.00 and set a “market outperform” rating for the company in a report on Thursday, May 9th. Finally, Piper Sandler reiterated an “overweight” rating and issued a $15.00 price target (down previously from $18.00) on shares of Paragon 28 in a report on Thursday, May 9th. Five equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus price target of $16.75.

About Paragon 28

Paragon 28, Inc develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems.